SEC Form 4 · accession 0001161697-16-000596
CATALYST PHARMACEUTICALS, INC. · CPRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Steve Miller
Officer — Chief Operating Officer
Period of report
Dec 30, 2015
Accepted (ET)
Jan 4, 2016 · 4:37 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001369568
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Options to purchase common stock | $2.53 | Dec 30, 2015 | A | 50,000 | A | Dec 30, 2016 | Dec 30, 2022 | Common Stock | 50,000 | 525,000 | D |
| Options to purchase common stock | $2.53 | Dec 30, 2015 | A | 50,000 | A | Dec 30, 2017 | Dec 30, 2022 | Common Stock | 50,000 | 575,000 | D |
| Options to purchase common stock | $2.53 | Dec 30, 2015 | A | 50,000 | A | Dec 30, 2018 | Dec 30, 2022 | Common Stock | 50,000 | 625,000 | D |